WGS Analysis of COVID-19 Positive Patients
NCT04353401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2024-03-22
Summary
We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
Conditions
- Coronavirus Infection
- COVID-19
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-03
- Primary Completion
- 2022-03-09
- Completion
- 2022-03-09
Countries
- United States
Study Locations
More Related Trials
-
SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.
NCT05567419 ·Status: UNKNOWN
-
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
NCT04567134 ·Status: UNKNOWN
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts
NCT04980560 ·Status: ACTIVE_NOT_RECRUITING
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
NCT01232595 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
NCT04335084 ·Status: COMPLETED ·Phase: PHASE2
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
NCT05150184 ·Status: COMPLETED
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Evaluation of a Diagnostic Enteric Card for Management of Diarrhea
NCT00736567 ·Status: COMPLETED
-
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NCT02237859 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method
NCT02558179 ·Status: UNKNOWN
-
Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms
NCT07105267 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84
NCT01296386 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
Westlake Gut Microbiome Study
NCT04435548 ·Status: WITHDRAWN
-
The Association of Gut Microbiota With COVID 19 Infection in Children
NCT05303155 ·Status: UNKNOWN
-
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
NCT05930197 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Fecal Therapy
NCT02046525 ·Status: COMPLETED ·Phase: PHASE2
-
Application of Fecal Microbiota Transplantation in Children With ASD
NCT04948814 ·Status: UNKNOWN ·Phase: PHASE1
-
NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
NCT04540406 ·Status: COMPLETED ·Phase: PHASE2